All Stories

  1. RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation
  2. Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
  3. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response
  4. LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
  5. Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB -Independent Tissue-Resident Macrophages
  6. The nature and nurture of cell heterogeneity: accounting for macrophage gene-environment interactions with single-cell RNA-Seq
  7. Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease
  8. A Novel Real Time Imaging Platform to Quantify Macrophage Phagocytosis
  9. ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons
  10. CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells
  11. Physiological Characterisation of Human iPS-Derived Dopaminergic Neurons
  12. The Productive Entry Pathway of HIV-1 in Macrophages Is Dependent on Endocytosis through Lipid Rafts Containing CD4
  13. Differentially expressed, variant U1 snRNAs regulate gene expression in human cells
  14. Derivation and Functional Analysis of Patient-Specific Induced Pluripotent Stem Cells as an In Vitro Model of Chronic Granulomatous Disease
  15. Several Commercially Available Anti-CCR5 Monoclonal Antibodies Lack Specificity and Should Be Used with Caution
  16. Transportin 3 Promotes a Nuclear Maturation Step Required for Efficient HIV-1 Integration
  17. Protein Kinase C and NF- B-Dependent CD4 Downregulation in Macrophages Induced by T Cell-Derived Soluble Factors: Consequences for HIV-1 Infection
  18. Functional human artificial chromosomes are generated and stably maintained in human embryonic stem cells
  19. Proteomic-Based Identification of CD4-Interacting Proteins in Human Primary Macrophages
  20. Generation of neutralizing aptamers against herpes simplex virus type 2: potential components of multivalent microbicides
  21. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1
  22. Episomal Transgene Expression in Pluripotent Stem Cells
  23. Protection of HIV Neutralizing Aptamers against Rectal and Vaginal Nucleases: IMPLICATIONS FOR RNA-BASED THERAPEUTICS
  24. Derivation and characterisation of the human embryonic stem cell line, OxF1
  25. The roles of apoptotic pathways in the low recovery rate after cryopreservation of dissociated human embryonic stem cells
  26. Enhancement of cell recovery for dissociated human embryonic stem cells after cryopreservation
  27. The 5′ Leader of the mRNA Encoding the Marek's Disease Virus Serotype 1 pp14 Protein Contains an Intronic Internal Ribosome Entry Site with Allosteric Properties
  28. Identification of an Intercistronic Internal Ribosome Entry Site in a Marek's Disease Virus Immediate-Early Gene
  29. HIV entry in macrophages is dependent on intact lipid rafts
  30. An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site
  31. Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3
  32. Inter-Oligomer Interactions of the Human Prion Protein Are Modulated by the Polymorphism at Codon 129
  33. Conformational pH dependence of intermediate states during oligomerization of the human prion protein
  34. Aptamers in the virologists' toolkit
  35. Oligomerization of the Human Prion Protein Proceeds via a Molten Globule Intermediate
  36. Molecular Heterosis of Prion Protein β-Oligomers
  37. An Aptamer That Neutralizes R5 Strains of Human Immunodeficiency Virus Type 1 Blocks gp120-CCR5 Interaction
  38. Structural characterization of an anti-gp120 RNA aptamer that neutralizes R5 strains of HIV-1
  39. The presence of valine at residue 129 in human prion protein accelerates amyloid formation
  40. Rapid formation of amyloid from  -monomeric recombinant human PrP in vitro
  41. Autocatalytic RNA cleavage in the human β-globin pre-mRNA promotes transcription termination
  42. Assessing potential: the development of selection procedures for the Oxford medical course
  43. Methionine 129 Variant of Human Prion Protein Oligomerizes More Rapidly than the Valine 129 Variant: IMPLICATIONS FOR DISEASE SUSCEPTIBILITY TO CREUTZFELDT-JAKOB DISEASE
  44. Structural Determinants of Conformationally Selective, Prion-binding Aptamers
  45. Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers
  46. Characterization of 2'-Fluoro-RNA Aptamers That Bind Preferentially to Disease-associated Conformations of Prion Protein and Inhibit Conversion
  47. Molecular epidemiology of dengue virus type 3 in Venezuela
  48. Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides
  49. High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands
  50. Structural characterization of a 2′F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120
  51. Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery
  52. Neurological manifestations of dengue infection
  53. Cell-surface heparan sulfate facilitates human immunodeficiency virus Type 1 entry into some cell lines but not primary lymphocytes
  54. Affinity and Kinetics of the Interaction between Soluble Trimeric OX40 Ligand, a Member of the Tumor Necrosis Factor Superfamily, and Its Receptor OX40 on Activated T Cells
  55. Comparison of p24 measurement by ELISA versus indicator cells for detecting residual HIV infectivity in vitro
  56. The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding
  57. Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site.
  58. RNA enzymes as tools for gene ablation
  59. Heterokaryons Formed between a Rat Myeloma and a Mouse Fibroblast Are Permissive for Entry of HIV Type 1
  60. A rodent cell line permissive for entry and reverse transcription of human immunodeficiency virus type 1 has a pre-integration block to productive infection
  61. Definition of the range and distribution of human immunodeficiency virus macrophage tropism using PCR-based infectivity measurements
  62. HIV-1 pseudotype virus containing a Cocal virus genome and an HIV envelope: construction, assay and use
  63. Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro
  64. A rat CD4 mutant containing the gp120-binding site mediates human immunodeficiency virus type 1 infection
  65. Inhibition of HIV-1 replication by ribozymes that show poor activityin vitro
  66. Gene Inhibition of HIV-1 Replication.
  67. Towards Gene-Inhibition Therapy: A Review of Progress and Prospects in the Field of Antiviral Antisense Nucleic Acids and Ribozymes
  68. Development of techniques to analyse the formation of HIV provirus in primary human macrophages
  69. Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA
  70. PCR and the cloning of receptor subtype genes
  71. First Workshop of the MRC AIDS-Directed Programme
  72. The Head-Tail Linker Protein of Bacteriophage T5: Genetic and Immunological Studies
  73. Host-adaptive Antigenic Variation in Bunyaviruses